EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities

Liangning Cui, Yiyi Wang, Lijun Wang, Jianhao Bai, Wanru Zhou, Manhui Zhu, Jianjun Zhou, Haiying Jin

Frontiers in Cell and Developmental Biology · 04.03.2026 · 14

DOI: 10.3389/fcell.2026.1758898 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 04.03.2026. Verfasst von Liangning Cui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lens epithelial cells (LECs) senescence is a central pathogenic mechanism in cataract formation, driven by a variety of chronic stressors such as oxidative damage, UV radiation, metabolic disturbances, and mechanical strain. When exposed to these stressors, LECs undergo a series of cellular responses, including stable cell cycle arrest, development of a senescence-associated secretory phenotype (SASP), and impaired autophagic flux. These alterations compromise the function of LECs, disrupt lens homeostasis, and promote the pro-inflammatory microenvironment that accelerates cataract progression. Recent advances in targeting senescent LECs have led to the development of promising pharmacological therapies, including senolytics and senomorphics. Senolytic agents, such as Dasatinib and Quercetin, selectively eliminate senescent cells, while senomorphic agents like Metformin and Rapamycin aim to modulate the senescence-associated secretory phenotype and restore cellular homeostasis. Despite these promising results, challenges remain, particularly in overcoming ocular drug delivery barriers. Nonetheless, the potential of targeting LECs senescence offers new therapeutic opportunities for cataract management. Collectively, these insights support a paradigm shift in cataract management. Rather than relying solely on surgical intervention, future strategies may emphasize biologically informed, disease-modifying, and preventive approaches that target cellular senescence.

Schlagwörter

Stichwörter der Autor:innen

cataractcellular senescencelens epithelial cellssenolyticssenomorphics

Autor:innen und Institutionen

  • Department of Ophthalmology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Research Center for Translational Medicine, Cancer Stem Cell Institute, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.

Zitieren

APA

Cui, L., Wang, Y., Wang, L., Bai, J., Zhou, W., Zhu, M., Zhou, J., & Jin, H. (2026). Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1758898

Vancouver

Cui L, Wang Y, Wang L, Bai J, Zhou W, Zhu M, et al. Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1758898

BibTeX
@article{Cui2026,
  author = {Cui, Liangning and Wang, Yiyi and Wang, Lijun and Bai, Jianhao and Zhou, Wanru and Zhu, Manhui and Zhou, Jianjun and Jin, Haiying},
  title = {Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1758898}
}
Kostenlos starten →